The Mannich reaction of 7-aryl-5,6-dihydropyrido [2,3-d]pyrimidines 3, easily accessible by condensation of 6-amino-1,3-dimethyluracil (1) with Mannich bases 2a -c, gives rise to a mixture of 7-aryl-6-(N, N-dimethylaminomethyl)pyrido [2,3-d]pyrimidines 6 and 7 as well as 1,2-bis-(7-arylpyrido[2,3-d]pyrimidin-6-yl)ethane 13 the ratio of which depends on the reaction conditions and the amine used. 6-Alkylamino-1,3-dimethyluracils 15 -18 were converted to the corresponding 5-(3-oxo-3-phenylpropyl)uracils 19 -22 by condensation with the Mannich base 2a. Ring closure of 19 -22 was performed by Vilsmeier formylation to afford the 8-alkyl-and 7,8-diaryl-5,8-dihydropyrido[2,3-d]pyrimidine-6-carbaldehydes 9 -12 via the corresponding iminium salts 27 -30.
Introduction
Among the methods for the preparation of substituted 1,3-dimethylpyrido [2,3-d] pyrimidine(1H,3H)-2,4-diones the condensation of 6-amino-1,3-dimethyluracil (1) with electrophilic reagents represents a frequently employed procedure [1 -7] . In this process the substitution pattern of the anellated pyridine ring system is determined by the structure of the biselectrophile. We succeeded in directly introducing a substituent in position 6 of the pyridopyrimidine by the condensation of 1 with arylalkanone Mannich bases 2 affording the oxidation product of 3 (Scheme 1), described already by Troschütz and Roth [1] . With modified reaction conditions only the 5,6-dihydro derivatives 3 were isolated in yields of 50 -80% without purification by column chromatography [8] . The aza-analogous arylalkyl ketone moiety of the anellated pyridine ring system 3 should allow an electrophilic attack at position 6 and lead to pyridopyrimidines with interesting pharmacological activities. Compounds of this type are known for their anticancer and antibacte-* Presented in part at the 7 th Conference on Iminium Salts (ImSaT-7), Bartholomä/Ostalbkreis, September 6 -8, 2005 . rial activities [9, 10] and are therefore important targets in medicinal chemistry. Reviewing this concept we employed the Vilsmeier formylation of 3 and isolated novel 6-substituted 1,3-dimethyl-7-phenylpyrido- [2,3-d] pyrimidine(1H,3H)-2,4-diones 4 and 5 ( Fig. 1 ) depending on the reaction conditions [8] . As part of our continuing interest in the reactivity of the methylene group towards electrophiles [8] the Mannich reaction should produce analogous compounds 6 and 7 (Fig. 1) . In addition, 6-substituted pyridopyrimidines were of interest for our project on compounds acting at adenosine receptors. Within the scope of our structure-activity studies concerning the affinity of amino-substituted pyrido [2,3-d] pyrimidines for A 1 -and A 2A -adenosine receptors we found that the pyridopyrimidine 8 ( Fig. 2) was a highly effective A 1 -receptor antagonist with a K i value of 5 nM at rat and 25 nM at human A 1 -receptors [11] . We decided to investigate the influence of substituents at position 7 and 8 on the affinity for adenosine receptors. We synthesized compounds with electron withdrawing groups at position 6 and 7 and in addition an alkyl or phenyl substituent at the nitrogen atom. Starting from 6-alkyland 6-phenylamino-1,3-dimethyluracils we prepared the compounds 9 -12. moser's salt) as well as morpholine hydrochloride and paraformaldehyde in ethanolic solution to afford via the Mannich compounds 4 and 5 their oxidation products 6 and 7 (Scheme 2). As expected, aminomethylation in position 6 had occurred, and the analytical and spectroscopic data of 6 and 7, namely IR, 1 H and 13 C NMR data (cf. Experimental Section) are in agreement with the proposed structure. TLC of the reaction mixture showed the formation of a by-product, the structure of which seemed to be always identical independent of the amine used. In order to isolate this novel compound we carried out the reaction at higher temperature using N, Ndimethylformamide as solvent. We identified the structure of this unexpected compound as 1,2-bis-(pyrido [2,3-d] pyrimidin-6-yl)ethane 13 (Scheme 2). The 1 H NMR spectrum shows the ethylene bridge as a singlet with 4 magnetically equivalent protons. The dimeric structure was unequivocally established by the mass spectrum (ESI, cf. Experimental Section).
Results and Discussion
We would like to discuss two different reaction mechanisms both initiated by elimination of the amine as the key step of the oxidative dimerization to afford the ethylene compound 13 at elevated temperatures. In analogy to the intramolecular Cope rearrangement both exocyclic sp 2 -hybridized vinyl carbon lated dihydropyridine ring system which is then oxidized to 13. N 6 -Substituted 6-amino-1,3-dimethyluracils 19 -22 were prepared by nucleophilic substitution of 6-chloro-1,3-dimethyluracil with appropriate amines to form the pyrimidines 15 -18 [12 -14] followed by Michael addition of the acrylophenone formed by amine elimination of the ketone Mannich bases 2. Ring closure to pyrido [2,3-d] pyrimidines 25 -28 in analogy to the formation of 3 described in the literature [8] did not occur (Scheme 5). Instead, the 5-(3-oxo-3-phenyl)propyl substituted uracils 19 -22 were isolated and their Vilsmeier formylation was successfully performed using a mixture of N, N-dimethylformamide and phosphorous oxychloride to afford 
Conclusions
We have demonstrated that the aza-analogous arylalkyl ketone moiety of the anellated pyridines is also available to aminomethylation reactions. Depending on temperature and solvent we isolated pyrido[2,3-d]pyrimidines 6, 7 and 13. Different mechanisms for the formation of the dimer 13 were discussed. As to our best knowledge this is a type of Mannich reaction characterized for the first time. Contrary to 1, N 6 -substituted 6-amino-1,3-dimethyluracils 15 -18 gave no ring closure with aryl ketone Mannich bases 2. But under Vilsmeier conditions a novel cyclization to substituted pyrido [2,3-d] pyrimidines was developed.
Experimental Section

General methods
Melting points are uncorrected and were recorded with a Stuart Scientific, SMP03 melting point apparatus, 1 H and 13 C NMR spectra (internal Me 4 Si) were recorded using a Bruker ARX 300 spectrometer (δ given in ppm, J in Hz), IR spectra (KBr pellet) were measured on a PerkinElmer FT-IR 16 PC spectrometer, ESI-MS spectra were taken on a Bruker LC esquire mass spectrometer (ESI) in a MeOH/water mixture by direct infusion; EI (electron impact) mass spectra were obtained with an ionization energy of 70 eV using a HP 5989 mass spectrometer and a direct inlet probe with a tungsten wire; m/z values are reported followed by the relative intensity in parentheses; elemental analysis was performed by the Microanalytical Laboratory of the Institute of Inorganic Chemistry, University of Kiel. Macherey-Nagel Polygram R SIL G/UV 254 on plastic sheets was used for TLC monitoring.
Synthesis of 7-arylpyrido[2,3-d]pyrimidines (6a -c)
A mixture of 7-aryl-5,6-dihydropyrido[2,3-d]pyrimidines 3a -c (4 mmol) and N, N-dimethylaminomethylene chloride (10 mmol) in ethanol (80 ml, 160 ml for 6c) was heated to 65 • C for 3 h. After cooling to room temperature the reaction mixture was concentrated under reduced pressure. Ethyl acetate (50 ml) was added to the residue and heated. The boiling mixture was filtered and the solid formed was washed two times with boiling ethyl acetate (50 ml). The precipitate was solved in water (100 ml). To the unsolvable residue after filtration was added 2 ml ammonia (3 N). The solid formed was collected by filtration, dried and purified by crystallization from diethyl ether (6a) or ethanol (6b, c). 
7-(4-
Bromophenyl)-1,3-(dimethyl)-6-(N,N-dimethylamino- methyl)-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-2,4- dione (6c)
Synthesis of 7-arylpyrido[2,3-d]pyrimidines (7a -c)
A mixture of 7-aryl-5,6-dihydropyrido[2,3-d]pyrimidine 3a -c (4 mmol), morpholine hydrochloride (8 mmol) and paraformaldehyde (10 mmol) was reacted as described for compounds 6a -c. Products 7a -c were purified by crystallization from ethanol. 
1,3-Dimethyl-6-(morpholinomethyl)-7-phenyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-2,4-dione (7a)
M
1,3-Dimethyl-7-(4-methylphenyl)-6-(morpholinomethyl)-1, 2,3,4-tetrahydropyrido-[2,3-d]pyrimidine-2,4-dione (7b)
7-(4-Bromophenyl)-1,3-dimethyl-6-(morpholinomethyl)-1,2, 3,4-tetrahydropyrido[2,3-d]pyrimidine-2,4-dione (7c)
Synthesis of 8-alkyl-7-aryl-2,4-dioxo-5,8-dihydropyrido-[2,3-d]pyrimidine-6-carbaldehydes (9 -12)
To phosphoryl chloride (3.0 g) was added N, Ndimethylformamide (3.0 g) drop by drop at 15 -35 • C and the mixture stirred for 1 h at r. t. After adding the uracil derivative (19 -22) (1 mmol) the solution was stirred overnight. The mixture was poured onto ice-water and made alkaline with NaHCO 3 . The solid formed was collected by filtration and purified by crystallization. -2,4-dioxo-7,8-diphenyl-1,3,5,8-tetrahydropyrido [2,3- N 1 -CH 3 ) , 33.1 (6-CH 2 ), 109.1 (C-4a), 128.6 (C-2'), 128.8 (C-3'), 136.0 (C-1'), 138.9 (C-6), 139.1 (C-1', C-5), 148.7 (C-8a), 151.6 (C-2), 161.1 (C-4) 6-substituted 1,3-dimethyl-5-(3-oxo-3-phenylpropyl)uracils (19 -22) A solution of 6-substituted 1,3-dimethyluracils (15 -18) (4 mmol) and arylalkanone Mannich bases 2a,c -d (8 mmol) was refluxed in ethanol/water (1 : 1, 20 ml). After cooling to room temperature the solid product filtered and recrystallized from isopropanol. If no solid was formed the solvent was removed under reduced pressure and diethyl ether was added to the residue. This mixture was stirred vigorously, the precipitate filtered and crystallized from isopropanol. 
1,3,8-Trimethyl-2,4-dioxo-7-phenyl-1,3,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-carbaldehyde (9a)
7-(4-
Bromophenyl)-1,3-dimethyl-2,4-dioxo-8-propyl- 1,3,5,8-tetrahydropyrido[2,3-d]pyrimidine-6-carbaldehyde (10c) M. p. 171 • C (isopropanol);
1,3-Dimethyl
1,2-Bis(1,3-dimethyl-2,4-dioxo-7-phenyl-1H,3H-pyrido[2,3-d]pyrimidin-6-yl]ethane (13a)
Synthesis of
1,3-Dimethyl-6-methylamino-5-(3-oxo-3-phenylpropyl)-uracil (19a)
